2016 Pharmaceutical M&A Scorecard

2016 Pharmaceutical M&A Scorecard
Merger and acquisition activity is constantly shaping and reshaping the pharmaceutical and biopharmaceutical industries. While 2016 did not go as expected from an M&A perspective what didn’t happen was every bit as important as what did happen. The 2016 Pharmaceutical & Biopharmaceutical Scorecard includes: - What happened and what was expected to happen? - Recap of key movements in 2016 - Detailed scorecard of 2016 M&A activity - What’s on the horizon for 2017?